Document

5-year outcome after PRP analogous Gold induced serum therapy

Description

The study evaluated the effectiveness of GOLDIC, a PRP analogue gold-induced serum therapy, in treating knee osteoarthritis over a 5-year period. Using KOOS, VAS score, and MRI documentation, 28 patients (31 knees) underwent treatment at four-week intervals. Results showed significant improvement in VAS scores and slowed osteoarthritis progression on MRI. Two patients required knee replacement. The study suggests GOLDIC as a promising treatment for knee conditions, but calls for further research, including randomized controlled trials and AI-supported image processing for analysis.

Content restricted!

You need to login to see this content or to become an ESSKA member.

Content restricted!

You need to login to see this content or to become an ESSKA member.

Gernot Felmet MD

Gernot Felmet

Dr. med. / Senior Consultant

Artico SportsClinic in Villingen-Schwenningen, Germany

U S

Ulrich Schneider

Professor Dr. med.

iRegMed, Rottach, Germany,

W D

William D. Murrel

MD

Abu Dhabi Knee and Sports Medicine, Healthpoint Hospital, Zayed Sports City, Abu Dhabi, United Arab Emirates

ESSKA Continuous Professional Education Partners